← Back

Quarterly subscription

Argentina High-Cost Monitor

Quarterly tracking of the high-cost drug market in Argentina and of its implications for the subscriber's portfolio.

Each edition consists of a report and an Excel file with every data series: payments from SURGE, the national reimbursement mechanism for high-cost treatments, by payer; centralized purchasing and tenders with unit prices; the gap between the price actually paid and the list price, and its relation to the reimbursement value, for up to five molecules defined with the subscriber (additional molecules are quoted separately); and the quarter's regulatory changes, each with its implication. The report closes with a section of implications for the subscriber's portfolio and is presented in a 60-minute session with the subscriber's team.

Who it is for
Access, pricing and finance teams at companies with products under SURGE or SIGMAC (the centralized purchasing scheme with direct deduction), and regional teams that report on Argentina every quarter.
When
Four editions a year, in February, May, August and November.
Price
From USD 1,500 per quarter, depending on the molecules tracked.
How to contract
Per quarter, paid in advance, or as an annual subscription with a single purchase order and four defined deliverables.
Information required
The list of molecules and payers of interest.

Request a subscription

White paper in preparation

El precio lo fija el que compra: high-cost drugs and access in Argentina (in Spanish).

A notice is sent by email on the day of publication.

The monitor does not include sales data by payer, interviews with payers (the purpose of the KHIN Panel) or pricing recommendations for a specific product (the purpose of the Decision Sprint).

Next step

A Decision Sprint on a portfolio molecule the monitor identifies as at risk.